OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 OLIGODENDROGLIOMA: ANALYSIS FROM THE POLA COHORT

被引：2

作者：

Kacimi, S. E. O. ^{[1
]}

Dehais, C. ^{[2
]}

Carpentier, C. ^{[1
]}

Chinot, O. ^{[3
]}

Bronnimann, C. ^{[4
]}

Vauleon, E. ^{[5
]}

Djelad, A. ^{[6
]}

Moyal, E. C. ^{[7
]}

Campone, M. ^{[8
]}

Ducloie, M. ^{[9
]}

Noel, G. ^{[10
]}

Cuzzubbo, S. ^{[11
]}

Thaillandier, L. ^{[12
,13
]}

Ramirez, C. ^{[14
,15
]}

Colin, C. ^{[16
]}

Appay, R. ^{[16
]}

Tabouret, E. ^{[17
]}

Nichelli, L. ^{[18
]}

Mathon, B. ^{[2
]}

Thomas, A. ^{[19
]}

Tran, S.

Bielle, F. ^{[20
]}

Alentor, A. ^{[2
]}

Labreche, K.

Idbaih, A.

Figarella-Branger, D. ^{[21
]}

Ducray, F. ^{[22
]}

Touat, M. ^{[2
]}

机构：

[1] Hop La Pitie Salpetriere, Inst Cerveau, Paris, France

[2] Hop Univ Pitie Salpetriere Charles Foix, APHP, Serv Neurol Mazarin 2, Paris, France

[3] Aix Marseille Univ, CHU Timone, Assistance Publ Hopi Marseille APHM, Dept Neurooncol, Marseille, France

[4] Univ Hosp Bordeaux, Dept Med Oncol, Bordeaux, France

[5] Ctr Eugene Marquis, Rennes, France

[6] Univ Hosp Lille, Dept Neurosurg, Lille, France

[7] Inst Univ Canc Toulouse Oncopole, Dept Radiat Oncol, Toulouse, France

[8] Inst Cancerol Ouest Pays Loire, Angers, France

[9] Hop Univ Pitie Salpetriere Charles Foix, Neurooncol, Paris, France

[10] Strasbourg Europe Canc Inst ICANS, Dept Radiotherapy, Strasbourg, France

[11] Hosp St Louis, APHP, Dept Neurol, Paris, France

[12] CHU Nancy, Serv Neurol Unite Neuro Oncol, Nancy, France

[13] CHU Nancy, Nancy, France

[14] Lucien Neuwirth Canc Inst, Dept Med Oncol, St Priest En Jarez, France

[15] Univ Hosp St Etienne, North Hosp, Dept Neurol, St Etienne, France

[16] Aix Marseille Univ, CNRS, Inst Neurophysiopathol, INP, Marseille, France

[17] Aix Marseille Univ, CNRS,CHU Timone,APHM,INP, Inst Neurophysiopathol, Serv Neurooncol, Marseille, France

[18] Sorbonne Univ, Grp Hosp Salpetriere, APHP, Serv Neuroradiol, Paris, France

[19] UNICANCER, Dept Radiotherapy, Ctr Paul Strauss, Strasbourg, France

[20] Hop Univ Pitie Salpetriere Charles Foix, APHP, Serv Neuropathol Raymond Escourolle Salpetriere C, Paris, France

[21] Aix Marseille Univ, La Timone Hosp, Dept Pathol & Neuropathol, Paris, France

[22] Civil Hosp Lyon, Pierre Wertheimer Hosp, Dept Neuro Oncol, Bron, France

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad137.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

KS02.5.A

引用

页数：1

共 31 条

[21] Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
Melike Pekmezci
Joanna J. Phillips
Fikret Dirilenoglu
Turkan Atasever-Rezanko
Tarik Tihan
David Solomon
Andrew Bollen
Arie Perry
Acta Neuropathologica, 2020, 139 : 597 - 600
[22] Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation
Lamba, Nayan
McAvoy, Malia
Kavouridis, Vasileios K.
Smith, Timothy R.
Touat, Mehdi
Reardon, David A.
Iorgulescu, J. Bryan
NEURO-ONCOLOGY PRACTICE, 2022, 9 (03) : 201 - 207
[23] Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
Pekmezci, Melike
Phillips, Joanna J.
Dirilenoglu, Fikret
Atasever-Rezanko, Turkan
Tihan, Tarik
Solomon, David
Bollen, Andrew
Perry, Arie
ACTA NEUROPATHOLOGICA, 2020, 139 (03) : 597 - 600
[24] The T2-FLAIR Mismatch Sign as an Imaging Indicator of IDH-Mutant, 1p/19q Non-Codeleted Lower Grade Gliomas: A Systematic Review and Diagnostic Accuracy Meta-Analysis
Adamou, Antonis
Beltsios, Eleftherios T.
Papanagiotou, Panagiotis
DIAGNOSTICS, 2021, 11 (09)
[25] Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
Habiba, Umma
Sugino, Hirokazu
Yordanova, Roumyana
Ise, Koki
Tanei, Zen-ichi
Ishida, Yusuke
Tanikawa, Satoshi
Terasaka, Shunsuke
Sato, Ken-ichi
Kamoshima, Yuuta
Katoh, Masahiko
Nagane, Motoo
Shibahara, Junji
Tsuda, Masumi
Tanaka, Shinya
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
[26] Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
Umma Habiba
Hirokazu Sugino
Roumyana Yordanova
Koki Ise
Zen-ichi Tanei
Yusuke Ishida
Satoshi Tanikawa
Shunsuke Terasaka
Ken-ichi Sato
Yuuta Kamoshima
Masahiko Katoh
Motoo Nagane
Junji Shibahara
Masumi Tsuda
Shinya Tanaka
Acta Neuropathologica Communications, 9
[27] 11 C-Methionine Integrated PET/MRI- Based Texture Analysis Features May Have a Potential Ability to Distinguish Oligodendroglioma (IDH-Mutant and 1p/19q-Codeleted) From Varied Gliomas
Zhao, Kai
Yu, Peng
Xue, Zhe
Liu, Jiajin
Yao, Anhui
Zhao, Yue
Yang, Fuxing
Tian, Jiahe
Xu, Bainan
ACADEMIC RADIOLOGY, 2020, 27 (07) : E159 - E167
[28] Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: An updated systematic review and meta-analysis
Do, Yoon Ah
Cho, Se Jin
Choi, Byung Se
Baik, Sung Hyun
Bae, Yun Jung
Sunwoo, Leonard
Jung, Cheolkyu
Kim, Jae Hyoung
NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[29] OUTCOME IN 1p/19q NON-CO-DELETED GLIOMA TREATED AT FIRST RECURRENCE WITH TEMOZOLOMIDE W/WO BEVACIZUMAB IS DEPENDENT ON IDH, MGMT AND CIMP STATUS, BUT NOT ON GRADE AT FIRST DIAGNOSIS. A REPORT FROM THE RANDOMIZED PHASE II EORTC TAVAREC TRIAL
French, Pim
de Heer, Iris
Draaisma, Kaspar
Kros, Johan
Taal, W.
Bromberg, Jacolien
Clement, Paul
Idbaih, Ahmed
De Vos, Filip
Wick, Antje
Mulholland, Paul
Taphoorn, Martin
Lewis, Joanne
Verschuere, Tina
Golfinopoulos, Vassilis
Gorlia, Thierry
van den Bent, Martin
NEURO-ONCOLOGY, 2017, 19 : 182 - 182
[30] EFFECT OF CONCURRENT AND ADJUVANT TEMOZOLOMIDE ON SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GRADE III GLIOMAS WITHOUT 1p/19q CO-DELETION: A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY (INTERIM RESULTS FROM THE KNOG-1101 STUDY)
Kim, Chae-Yong
Hwang, Kihwan
Kim, Tae Min
Park, Chul-Kee
Chang, Jong Hee
Jung, Tae-Young
Lee, Dong-Eun
Joo, Jungnam
Choe, Ghee Young
Kim, Yu Jung
Choi, Byung Se
Kim, Jeong Hoon
NEURO-ONCOLOGY, 2018, 20 : 23 - 23

← 1 2 3 4 →